Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$19.02 - $30.13 $744,271 - $1.18 Million
39,131 Added 15.71%
288,288 $6.41 Million
Q3 2023

Nov 08, 2023

BUY
$30.46 - $46.04 $502,955 - $760,212
16,512 Added 7.1%
249,157 $7.59 Million
Q2 2023

Aug 09, 2023

SELL
$31.57 - $37.73 $2.01 Million - $2.4 Million
-63,617 Reduced 21.47%
232,645 $8.69 Million
Q1 2023

May 10, 2023

BUY
$29.72 - $41.45 $23,805 - $33,201
801 Added 0.27%
296,262 $9.47 Million
Q4 2022

Feb 09, 2023

SELL
$30.23 - $38.71 $64,027 - $81,987
-2,118 Reduced 0.71%
295,461 $10.5 Million
Q3 2022

Oct 31, 2022

BUY
$22.51 - $38.27 $207,879 - $353,423
9,235 Added 3.2%
297,579 $8.66 Million
Q2 2022

Aug 05, 2022

BUY
$20.97 - $37.47 $3.01 Million - $5.38 Million
143,576 Added 99.18%
288,344 $6.46 Million
Q1 2022

May 13, 2022

SELL
$34.38 - $65.77 $5.18 Million - $9.9 Million
-150,583 Reduced 50.98%
144,768 $10.5 Million
Q4 2021

Apr 08, 2022

BUY
$63.78 - $97.86 $18.8 Million - $28.9 Million
294,986 Added 80818.08%
295,351 $20.8 Million
Q4 2021

Feb 14, 2022

SELL
$63.78 - $97.86 $9.46 Million - $14.5 Million
-148,378 Reduced 99.75%
365 $20.8 Million
Q3 2021

Oct 20, 2021

BUY
$45.58 - $88.24 $198,592 - $384,461
4,357 Added 3.02%
148,743 $23.7 Million
Q2 2021

Aug 12, 2021

BUY
$34.4 - $48.34 $24,699 - $34,708
718 Added 0.5%
144,386 $13.7 Million
Q1 2021

May 06, 2021

BUY
$23.17 - $38.3 $2.26 Million - $3.74 Million
97,732 Added 212.76%
143,668 $10.4 Million
Q4 2020

Feb 01, 2021

BUY
$18.28 - $23.85 $839,710 - $1.1 Million
45,936 New
45,936 $2.18 Million
Q3 2020

Nov 03, 2020

SELL
$12.91 - $18.51 $18,590 - $26,654
-1,440 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$9.68 - $17.5 $13,939 - $25,200
1,440 New
1,440 $203,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.52B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Baltimore Washington Financial Advisors, Inc. Portfolio

Follow Baltimore Washington Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baltimore Washington Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baltimore Washington Financial Advisors, Inc. with notifications on news.